1304 related articles for article (PubMed ID: 14765315)
1. Botulinum toxin injection after biliary sphincterotomy.
Gorelick A; Barnett J; Chey W; Anderson M; Elta G
Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315
[TBL] [Abstract][Full Text] [Related]
2. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
[TBL] [Abstract][Full Text] [Related]
3. Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy?
Arguedas MR; Linder JD; Wilcox CM
Endoscopy; 2004 Feb; 36(2):174-8. PubMed ID: 14765316
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB
Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injection after biliary sphincterotomy.
Cotton PB; Hawes RH
Endoscopy; 2004 Aug; 36(8):744; author reply 745. PubMed ID: 15280987
[No Abstract] [Full Text] [Related]
7. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM).
Maldonado ME; Brady PG; Mamel JJ; Robinson B
Am J Gastroenterol; 1999 Feb; 94(2):387-90. PubMed ID: 10022634
[TBL] [Abstract][Full Text] [Related]
8. [Sphincter of Oddi disfunction in "idiopathic" recurrent pancreatitis].
Wehrmann T; Zipf A; Caspary WF; Jung M
Dtsch Med Wochenschr; 1996 Jun; 121(24):781-7. PubMed ID: 8654212
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial comparing needle-knife and pull-sphincterotome techniques for pancreatic sphincterotomy in high-risk patients.
Varadarajulu S; Wilcox CM
Gastrointest Endosc; 2006 Nov; 64(5):716-22. PubMed ID: 17055863
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors in endoscopic manometry for suspected dysfunction of Oddi's sphincter].
Wehrmann T; Wendler OG; Jung M; Caspary WF
Dtsch Med Wochenschr; 1997 Jun; 122(25-26):808-14. PubMed ID: 9244668
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.
Tarnasky P; Cunningham J; Cotton P; Hoffman B; Palesch Y; Freeman J; Curry N; Hawes R
Endoscopy; 1997 May; 29(4):252-7. PubMed ID: 9255527
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
14. Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction.
Cheon YK; Cho YD; Moon JH; Im HH; Jung Y; Lee JS; Lee MS; Shim CS
Gastrointest Endosc; 2009 May; 69(6):1111-6. PubMed ID: 19243765
[TBL] [Abstract][Full Text] [Related]
15. Intrasphincteric botulinum toxin type A for the diagnosis of sphincter of Oddi dysfunction: a case report.
Banerjee B; Miedema B; Saifuddin T; Marshall JB
Surg Laparosc Endosc Percutan Tech; 1999 Jun; 9(3):194-6. PubMed ID: 10803999
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic and therapeutic possibilities in suspected Oddi's sphincter dysfunction].
Wehrmann T; Lembcke B; Jung M
Z Gastroenterol; 1994 Dec; 32(12):694-701. PubMed ID: 7871862
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction.
Geenen JE; Hogan WJ; Dodds WJ; Toouli J; Venu RP
N Engl J Med; 1989 Jan; 320(2):82-7. PubMed ID: 2643038
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of botulinum toxin in gastrointestinal disorders].
Zepeda-Gómez S; Valdovinos-Díaz MA
Rev Gastroenterol Mex; 2002; 67(2):126-33. PubMed ID: 12214336
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin may predict the outcome of endoscopic sphincterotomy in episodic functional post-cholecystectomy biliary pain.
Murray W; Kong S
Scand J Gastroenterol; 2010 May; 45(5):623-7. PubMed ID: 20156033
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
